30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Nancy Lurker

Insider profile

Currently holds positions in Aquestive Therapeutics Inc and EyePoint Inc

Performance

Overall performance
3.4

Performance over holding periods
4.2
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 13% 68% 82%
Transactions
11 36% Buy
34 71% Buy
47 69% Buy

Performance for realised trades
4.4
Average return 53%
Success rate 73%
Average holding period 220
Transactions 28

Positions

Position Company Period
Independent Director Aquestive Therapeutics Inc April 1, 2018 -
President, Chief Executive Officer, Independent Director EyePoint Inc Sept. 15, 2016 -
Independent Director Keenova Therapeutics PLC June 28, 2013 - July 20, 2016
President, Chief Executive Officer, Director Interpace Biosciences Inc Dec. 7, 2015 - Dec. 22, 2015
Chief Executive Officer, Director Interpace Biosciences Inc Nov. 18, 2008 - Dec. 7, 2015
Independent Director Auxilium Pharmaceuticals LLC June 1, 2011 - Jan. 29, 2015

Nancy Lurker's trades of Collegium Pharmaceutical Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-15 2026-05-13 S Sale
34,836 -28.1%
487.32
US$1,129,532
34,836 -28.1% 487.32 US$1,129,532
2026-05-13 2026-05-13 PrS Proposed sale
98,217
455.15
US$3,909,467
98,217 455.15 US$3,909,467
2025-12-05 2025-12-04 S Sale
30,840 +21.7%
378.22
US$39,389
30,840 +21.7% 378.22 US$39,389
2025-12-04 2025-12-04 PrS Proposed sale
9,300
15.11
US$140,477
9,300 15.11 US$140,477
2025-12-01 2025-11-28 S Sale
500 -0.2%
14.95
US$7,475
500 -0.2% 14.95 US$7,475
2025-11-28 2025-11-28 PrS Proposed sale
500
14.95
US$7,475
500 14.95 US$7,475
2025-12-01 2025-11-26 S Sale
200 -0.1%
14.95
US$2,990
200 -0.1% 14.95 US$2,990
2025-11-26 2025-11-26 PrS Proposed sale
200
14.95
US$2,990
200 14.95 US$2,990
2024-08-20 2024-08-16 B Purchase
3,173 +3.4%
7.88
US$25,003
3,173 +3.4% 7.88 US$25,003
2024-01-25 2024-01-24 S Sale
29,956 -18.1%
24.98
US$748,250
29,956 -18.1% 24.98 US$748,250
2024-01-24 2024-01-24 PrS Proposed sale
29,956
24.98
US$748,250
29,956 24.98 US$748,250
2024-01-25 2024-01-23 S Sale
5,044 -3.0%
24.97
US$125,950
5,044 -3.0% 24.97 US$125,950
2024-01-23 2024-01-23 PrS Proposed sale
5,044
24.97
US$125,950
5,044 24.97 US$125,950
2023-12-06 2023-12-04 S Sale
20,000 -10.5%
20.76
US$415,200
20,000 -10.5% 20.76 US$415,200
2023-12-04 2023-12-04 PrS Proposed sale
20,000
20.76
US$415,164
20,000 20.76 US$415,164
2023-12-04 2023-12-04 PrS Proposed sale
20,000
20.76
US$415,164
20,000 20.76 US$415,164
2021-11-17 2021-11-15 PlS Planned sale
10,000 -8.8%
20.15
US$201,480
10,000 -8.8% 20.15 US$201,480
2020-03-11 2020-03-10 B Purchase
98,000 +20.6%
1.06
US$104,027
98,000 +20.6% 1.06 US$104,027
2019-04-01 2019-03-29 B Purchase
28,500 +13.5%
1.76
US$50,246
28,500 +13.5% 1.76 US$50,246
2017-06-14 2017-06-14 B Purchase
56,700 +inf%
1.76
US$99,962
56,700 +inf% 1.76 US$99,962
2014-11-12 2014-11-10 B Purchase
16,000 +3.1%
1.69
US$27,090
16,000 +3.1% 1.69 US$27,090
2014-11-12 2014-11-07 B Purchase
33,000 +6.8%
1.77
US$58,502
33,000 +6.8% 1.77 US$58,502
2014-11-07 2014-11-06 B Purchase
1,000 +0.2%
1.60
US$1,600
1,000 +0.2% 1.60 US$1,600
2014-11-07 2014-11-05 B Purchase
500 +0.1%
1.72
US$860
500 +0.1% 1.72 US$860
2014-11-07 2014-11-05 B Purchase
500 +0.1%
1.72
US$860
500 +0.1% 1.72 US$860
2014-11-07 2014-11-05 B Purchase
27,500 +6.0%
1.75
US$48,078
27,500 +6.0% 1.75 US$48,078
2014-11-07 2014-11-05 B Purchase
27,500 +6.3%
1.74
US$47,737
27,500 +6.3% 1.74 US$47,737
2009-08-18 2009-08-18 B Purchase
6,000 +4.2%
5.17
US$31,039
6,000 +4.2% 5.17 US$31,039
2009-08-18 2009-08-17 B Purchase
3,960 +2.8%
5.05
US$19,998
3,960 +2.8% 5.05 US$19,998